ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors|Undifferentiated Pleomorphic Sarcoma|Squamous Cell Carcinoma of the Head and Neck|Carcinoma of the Breast
Interventions: DRUG: ABBV-085
Sponsor: AbbVie